. 2015 Jul 15;8(7):11337–11341.

Table 1.

Comparison of patient characteristics active and inactive and the control group

	Active group (n=64)	Inactive group (n=51)	Control group (n=64)	P
Age, year	11.32 ± 3.57	11.15 ± 3.45	10.76 ± 3.34	NS^, NS^, NS^**
Sex (Male/Female)	33/31	25/26	33/31	NS^, NS^, NS^**
MPV, fL	8.23 ± 1.16	7.00 ± 1.08	6.77 ± 1.08	<0.001^, <0.001^, NS^**
PDW, %	17.84 ± 1.06	17.31 ± 1.09	17.19 ± 0.93	NS^, 0.018^, NS^**
PLT count x 10³/mm³	340.1 ± 91.7	282.7± 74.2	263.9 ± 45.7	0.002^, <0.001^, 0.030^**
ESR, mm/h	25.5 ± 13.5	14.2 ± 12.8	5.6 ± 4.8	<0.001^, <0.001^, 0.030^**
CRP, mg/dl	10.15 ± 9.03	2.54 ± 2.53	0.30 ± 0.25	<0.001^, <0.001^, <0.001^**
WBC, /mm³	9.43 ± 3.20	10.05 ± 2.79	8.26 ± 1.93	NS^, 0.021^, <0.001^**
NLR	2.11 ± 1.19	2.03 ± 1.51	1.33 ± 0.66	NS^, <0.001^, 0.017^**
Hemoglobin, g/dl	11.45 ± 1.42	12.89 ± 1.25	12.91 ± 1.13	<0.001^, <0.001^, NS^**

MPV-mean platelet volume; PDW-platelet distribution width; PLT-Platelet count; ESR-erythrocyte sedimentation rate; CRP-C-reactive protein; WBC-white blood cell; NLR-neutrophil-lymphocyte ratio.

Active disease vs. inactive disease;

^**

Active disease vs. control group;

^***

Inactive disease vs. control group, NS-Not significant.